Country: Israel
Language: English
Source: Ministry of Health
IOHEXOL
ELDAN ELECTRONIC INSTRUMENTS CO LTD
V08AB02
SOLUTION FOR INJECTION
IOHEXOL 518 MG/ML
I.V
Required
GE HEALTHCARE AS, NORWAY
IOHEXOL
IOHEXOL
X-ray contrast medium for use in adults and children for cardioangiography, arteriography, urography, phlebography and CT- enhancement. Lumbar, thoracic, cervical myelography and computed tomography of the basal cisterns, following subarachnoid injection. Arthrography, endoscopic retrograde pancreatography (ERP), endoscopic retrograde cholangiopancreatography (ERCP), herniography, hysterosalpingography, sialography and studies of the gastrointestinal tract.
2021-04-30
OMNIPAQUE INJECTION X-RAY CONTRAST MEDIUM Page 1 of 19 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT OMNIPAQUE 240 MG I/ML, 300 MG I/ML, 350 MG I/ML 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Iohexol 518mg/ml equivalent to 240mg/ml iodine. Iohexol 647 mg/ml equivalent to 300mg/ml Iodine Iohexol 755 mg/ml equivalent to 350 mg/ml iodine. Iohexol is a non-ionic, monomeric, triiodinated, water-soluble X-ray contrast medium. The osmolality and viscosity values of Omnipaque 240, 300, 350 mg I\ml are as follows: Concentration Osmolality * Osm/kg H 2 O Viscosity (mPa ⋅ s)* 37°C 20°C 37°C 240 mg I/ml 300 mg I/ml 350 mg I/ml 0.51 0.64 0.78 5.6 11.6 23.3 3.3 6.1 10.6 * Method: Vapour - pressure osmometry. This medicinal product contains 0.012mg sodium per ml, i.e. essentially sodium free. For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Solution for injection. A clear, colourless to pale yellow, sterile aqueous solution. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS This medicinal product is for diagnostic use only. X-ray contrast medium for use in adults and children for cardioangiography, arteriography, urography, phlebography and CT-enhancement. Lumbar, thoracic, cervical myelography and computed tomography of the basal cisterns, following subarachnoid injection. Arthrography, endoscopic retrograde pancreatography (ERP), endoscopic retrograde cholangiopancreatography (ERCP), herniography, hysterosalpingography, sialography and studies of the gastrointestinal tract. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION The dosage vary depending on the type of examination age, weight, cardiac output and general condition of the patient and the technique used. Usually, the same iodine OMNIPAQUE INJECTION X-RAY CONTRAST MEDIUM Page 2 of 19 concentration and volume is used as with other iodinated X-ray contrast media in current use. Adequate hydration should be assured before and after administration as for other contrast media. For intravenous, intra-arterial and intrathecal Read the complete document